Home › Funds › ACT Capital Partners, L.P. › KRYS
ACT Capital Partners, L.P. position in KRYS
KRYSTAL BIOTECH INC · Health Care
ACT Capital Partners, L.P. reported holding 42,000 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$14.0M, representing 9.47% of its reported portfolio and ranking #2 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s KRYS position evolved
ACT Capital Partners, L.P. first disclosed a stake in KRYS in Q3 2026 at 42,000 shares (US$14.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 42.00K | $13.97M | New |
About KRYS and 13F data
KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 49 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KRYS
- Avoro Capital Advisors LLC 2.89M sh · $1.07B · Q2 2026
- Soleus Capital Management, L.P. 939.25K sh · $349.09M · Q2 2026
- Hood River Capital Management LLC 663.38K sh · $246.56M · Q2 2026
- Redmile Group, LLC 632.00K sh · $234.90M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 570.15K sh · $211.91M · Q2 2026
- Frazier Life Sciences Management, L.P. 481.31K sh · $178.89M · Q2 2026
- VESTOR CAPITAL, LLC 700.91K sh · $78.19M · Q2 2026
- BRAIDWELL LP 128.97K sh · $47.94M · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held KRYS?
ACT Capital Partners, L.P. has disclosed KRYS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in KRYS?
As of Q3 2026, ACT Capital Partners, L.P. holds 42.00K shares of KRYS (KRYSTAL BIOTECH INC), valued at $13.97M, representing 9.47% of its reported portfolio and ranking #2.
Has ACT Capital Partners, L.P. been buying or selling KRYS?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in KRYS.
Which other funds hold KRYS?
Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.